Morphine Market: Revenue, Type and Applications forecast to 2022

This report provides an extensive analysis of the current and emerging market trends and dynamics in the global morphine market.

Logo

Portland, OR -- (SBWire) -- 10/04/2017 --Morphine is an analgesic and narcotic drug obtained from opium for treatment of moderate to severe pain. As per the International Narcotics Control Board, 92 % of the worlds morphine is consumed by 17% of the worlds population, while the rest of the world population consumes around 8% of morphine.

The growth of the market for is driven by factors such as lifestyle changes that lead to pain and growth in number of surgical procedures as the drug is prescribed for pain relief post-surgery. However, the addictive nature of the drug restricts the growth of the global morphine market.

Access Full Summary @ https://www.alliedmarketresearch.com/morphine-market

The report segments the medical crutches market on the basis of type, application, and geography. Based on type, the market is segmented into oral tablets, injection, capsule, and others. By application, it is classified into anesthesia, cough suppressant, and diarrhea suppressant. Geographical breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and LAMEA.

Request Sample Report: https://www.alliedmarketresearch.com/request-toc-and-sample/3654

Comprehensive competitive analysis and profiles of the major market players such as Mallinckrodt Pharmaceuticals, Alcaliber SA, Purdue Pharma L.P, Sanofi Winthrop Industrie, Macfarlan Smith, Sun Pharmaceutical Industries Ltd., Qinghai Pharmaceutical Co. Ltd., Northeast Pharmaceutical Group Co., Ltd., and others are provided in this report.

Morphine Market Key Segments:

By Type

-Oral Tablets
-Injection
-Capsule
-Others

By Application

-Anesthesia
-Cough Suppressant
-Diarrhea Suppressant

Media Relations Contact

Allied Market Research
800-792-5285
https://www.alliedmarketresearch.com

View this press release online at: http://rwire.com/869379